Jeff Yass’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$243K Sell
11,031
-19,374
-64% -$389K ﹤0.01% 11476
2026
Q2
$624K Sell
30,405
-7,673
-20% -$130K ﹤0.01% 9385
2026
Q1
$605K Buy
38,078
+27,310
+254% +$593K ﹤0.01% 9169
2025
Q4
$283K Sell
10,768
-9,531
-47% -$247K ﹤0.01% 10082
2025
Q3
$459K Sell
20,299
-149,666
-88% -$3.08M ﹤0.01% 9164
2025
Q2
$3.38M Buy
169,965
+108,227
+175% +$2.11M ﹤0.01% 4727
2025
Q1
$1.04M Buy
61,738
+34,496
+127% +$588K ﹤0.01% 7154
2024
Q4
$503K Buy
27,242
+12,675
+87% +$247K ﹤0.01% 8645
2024
Q3
$317K Buy
+14,567
New +$326K ﹤0.01% 9485
2024
Q2
– Sell
-67,686
Closed -$1.41M – 12372
2024
Q1
$1.47M Buy
67,686
+52,864
+357% +$1.31M ﹤0.01% 6055
2023
Q4
$429K Buy
+14,822
New +$397K ﹤0.01% 9046
2023
Q3
– Sell
-53,975
Closed -$1.84M – 12288
2023
Q2
$2M Sell
53,975
-35,503
-40% -$1.24M ﹤0.01% 5167
2023
Q1
$2.79M Buy
89,478
+2,059
+2% +$66.3K ﹤0.01% 4459
2022
Q4
$2.6M Sell
87,419
-31,630
-27% -$1.13M ﹤0.01% 4242
2022
Q3
$4.54M Buy
119,049
+62,463
+110% +$3.13M ﹤0.01% 3319
2022
Q2
$3.09M Buy
56,586
+6,990
+14% +$384K ﹤0.01% 4017
2022
Q1
$3.1M Sell
49,596
-17,715
-26% -$1.17M ﹤0.01% 4565
2021
Q4
$6.77M Sell
67,311
-46,951
-41% -$4.13M ﹤0.01% 3254
2021
Q3
$10.3M Sell
114,262
-50,357
-31% -$4.58M ﹤0.01% 2823
2021
Q2
$15.2M Buy
164,619
+20,281
+14% +$1.62M ﹤0.01% 2361
2021
Q1
$13.9M Buy
144,338
+43,484
+43% +$4.49M ﹤0.01% 2323
2020
Q4
$5.25M Buy
+100,854
New +$4.21M ﹤0.01% 3342
2020
Q2
– Sell
-98,923
Closed -$1.06M – 10344
2020
Q1
$1.06M Buy
98,923
+45,800
+86% +$638K ﹤0.01% 5265
2019
Q4
$685K Buy
+53,123
New +$631K ﹤0.01% 6301
2018
Q4
– Sell
-25,298
Closed -$99K – 9229
2018
Q3
$99K Buy
25,298
+5,570
+28% +$23.8K ﹤0.01% 8606
2018
Q2
$82K Buy
19,728
+8,749
+80% +$34.7K ﹤0.01% 9121
2018
Q1
$44K Buy
+10,979
New +$48.3K ﹤0.01% 8988

Other funds holding FLGT

Jeff Yass's FLGT Position: Q3 2026 in Review

Jeff Yass reduced its Fulgent Genetics (FLGT) stake by 64% in Q3 2026, selling an estimated $389K and leaving 11,031 shares worth $243K. The position accounts for ﹤0.01% of the portfolio, ranked #11476.

Jeff Yass first reported a position in FLGT in Q1 2018 and has held it in 27 quarters since. The position peaked at $15.2M in Q2 2021. 140 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

  • Jeff Yass held 11,031 shares of Fulgent Genetics worth $243K as of Q3 2026.
  • Jeff Yass sold 19,374 Fulgent Genetics shares in Q3 2026, an estimated $389K.
  • Fulgent Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #11476 holding.
  • Jeff Yass first reported a position in Fulgent Genetics in Q1 2018 and has held it in 27 quarters since.
  • Jeff Yass's Fulgent Genetics position peaked at $15.2M in Q2 2021.
  • 140 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.